Annual report pursuant to Section 13 and 15(d)

Marketable Equity Securities - Schedule of Investments in Marketable Equity Securities (Details)

v3.20.2
Marketable Equity Securities - Schedule of Investments in Marketable Equity Securities (Details) - USD ($)
Dec. 31, 2019
Dec. 31, 2018
Schedule Of Available For Sale Securities [Line Items]    
Cost Basis $ 755,487 $ 755,487
Gross Unrealized Gains 1,005,825 812,120
Value 1,761,312 1,567,607
Common Stock    
Schedule Of Available For Sale Securities [Line Items]    
Cost Basis 755,487 755,487
Gross Unrealized Gains 1,005,825 812,120
Value $ 1,761,312 $ 1,567,607